Correction of Selenium Deficiency Has Effect on Thyroid Function
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
Previous literature has found potential association between selenium deficiency and inactivated glutathione peroxidase and deiodinase, which may contribute to subsequent elevation of T4 and ratio of T4/T3. Conduction of a case-control study (ID: Liuyanping3) has been applied on Clinicaltrials.gov to further elucidate effect of selenium deficiency on thyroid function. Based on its data, the investigators will perform a randomized, placebo-controlled,single-blinded crossover study on 20 participants with selenium deficiency to verify health consequence of selenium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2018
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2018
CompletedFirst Posted
Study publicly available on registry
February 26, 2018
CompletedStudy Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedMay 31, 2018
May 1, 2018
3 months
February 7, 2018
May 29, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
comparison of thyroid function
comparison of thyroid function between administration of selenium supplementation and placebo
plasma sample will be collected at -1w/4w/8w/12w
Secondary Outcomes (3)
comparison of serum selenium
plasma sample will be collected at -1w/4w/8w/12w
comparison of erythrocyte glutathione peroxidase activity
plasma sample will be collected at -1w/4w/8w/12w
comparison of serum deiodinase activity
plasma sample will be collected at -1w/4w/8w/12w
Study Arms (2)
A
ACTIVE COMPARATORParticipants will be administered firstly selenium-rich corn powder 20g/d for 1 month and ordinary corn powder 20g/d for another month subsequently with a month washout period.
B
PLACEBO COMPARATORParticipants will be administered firstly ordinary corn powder 20g/d for 1 month and selenium-rich corn powder 20g/d for another month subsequently with a month washout period.
Interventions
administration of selenium-rich corn powder 20g/d offering selenium 100μg/d
ordinary corn powder,20g/d(selenium contain \<0.5ug/20g).
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of selenium deficiency through serum selenium test in previous phase (ID: Liuyanping3) of the study
- Should have stable body weight in the latest 3 months;
- Should be not prescribed with thyroid hormone replacement therapy
- Should be without medical history of thyroid surgery or iodine radiotherapy
- Should have normal FT3, FT4 and TSH.
You may not qualify if:
- Clinical diagnosis of acute critical illness in the latest 1 year
- Have had weight fluctuation by more than 5%
- Eating disorders
- Neuropsychological disorders
- Allergy to corn or yeast
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- All participants will be blinded. Both the selenium-rich corn powder and the ordinary corn powder (placebo) have the same smell, color and taste.
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- nutrition physician
Study Record Dates
First Submitted
February 7, 2018
First Posted
February 26, 2018
Study Start
September 1, 2018
Primary Completion
December 1, 2018
Study Completion
April 1, 2019
Last Updated
May 31, 2018
Record last verified: 2018-05